News | June 04, 2014

New Performance Metrics for Cath PCI Accreditation Published by Accreditation for Cardiovascular Excellence

New performance metrics support quality standards for interventional cardiology best practices

June 4, 2014 — The Accreditation for Cardiovascular Excellence (ACE) Board of Directors has approved a new set of Performance Metrics for Cath PCI Accreditation. These metrics have been published and are now available for download on the ACE website or are available in hard copy.

ACE updated its Cath/PCI performance metrics to align with the NCDR CathPCI Registry, NCDR ACTION Registry and the Hospital Compare data. Thirty-six performance metrics in PCI, Diagnostic Cath, STEMI/NSTEMI and Medicare Hospital Compare Outcomes have been updated.

"It is critically important to align performance metrics with cath lab documentation," said Gregory J. Dehmer, M.D., FACC, FACP, FAHA, FSCAI and ACE board chair. "Incorporating these performance metrics into the ACE accreditation program maintains best practices for interventional cardiology."

SCAI 2013-14 President Ted A. Bass, M.D., FSCAI, is a long-time advocate of efforts, such as ACE's, that promote adherence to quality standards in cardiac cath labs. "I am excited by the rapidly growing number of cath labs that are applying for ACE review and accreditation," said Bass. "Cath lab accreditation is becoming a must-have for interventional cardiology labs."

For more information:

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Overlay Init